whereby the company has acquired Novartis vaccines business and divested its marketed oncology portfolio to Novartis India. This follows a global transaction between GlaxoSmithKline plc ...

Teva Pharmaceutical Industries Ltd. ADR-2.23% $19.91B ...

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

In a report released today, Emily Field from Barclays maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a price target of £14.50. The company’s shares closed yesterday at ...

Responsible transformation focuses on sustainable, smaller-scale projects that form part of a larger transformation roadmap.

As of November 08, 2024, GSK plc had a $73.1 billion market capitalization, putting it in the 96th percentile of companies in the Pharmaceuticals industry. Currently, GSK plc’s price-earnings ratio is ...

Integrating industry self-regulation into the education of future professionals is key to fostering a culture of responsible business practices. Law schools, business schools and public policy ...